Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Participating on CanBiotech
BioDevicesBiz - Medical Devices and Diagnostics Portal and B2B Marketplace Innovations in Drug Design Forum
Site Search:
    Home Directory News Community
Go Back
  Agilent Technologies to Acquire Silicon Genetics, Leading Provider of Life Science Informatics
Agilent Technologies
23/08/2004 00:00


PALO ALTO and REDWOOD CITY, Calif., Aug. 23, 2004 -- Agilent Technologies Inc. (NYSE: A) and Silicon Genetics today announced an agreement for Agilent to acquire Silicon Genetics, a leading provider of software solutions for life science discovery.

With the addition of Silicon Genetics' genomics data analysis and management tools to its portfolio, Agilent will become a market leader in life science informatics. The acquisition is subject to closing conditions, and financial details of the agreement were not disclosed.

'Silicon Genetics brings Agilent an outstanding informatics product portfolio and a strong team of people with extensive experience in software development, marketing, sales and support,' said Fran DiNuzzo, vice president and general manager of Agilent's Integrated Biology Solutions business. 'Our combined organizations will offer customers an unparalleled range of informatics solutions spanning applications in gene expression, genotyping and protein identification.'

Silicon Genetics, privately held, has been recognized as one of the fastest-growing technology companies in North America with inclusion on the Deloitte Technology FAST 500 and several other industry rankings. Silicon Genetics' customers include more than 600 leading pharmaceutical companies, academic institutions and major research organizations around the world. Based in Redwood City, Calif., Silicon Genetics employs 50 people, most of whom are expected to join Agilent.

Together, the staffs of Silicon Genetics and Agilent will form a life science informatics team that will be an incubator for informatics products spanning DNA, RNA, protein and pathway applications. The team will work on developing the products of Silicon Genetics, the Agilent Spectrum Mill proteomics workbench, the Agilent Synapsia informatics workbench and more.

'We plan to continue development and support of each of these product lines with a commitment to openness, industry standards, and interoperability with other instrument hardware and software providers,' said DiNuzzo. 'We see informatics as a key to advancing integrated biological research, and our goal is to provide customers with functionality in new research areas to enhance their productivity, creativity and research success.'

Silicon Genetics' key products include:

o GeneSpring, a powerful visualization and analysis solution designed for use with genomic expression data on the desktop.

o Varia, the first generation of genetic analysis software designed for high-volume genetic variation analysis on a standalone workbench.

o GeNet, a scalable repository for expression data.

'This is an extremely exciting opportunity for Silicon Genetics' customers and employees,' said Andrew Conway, the company's founder and chairman. 'Agilent has broad knowledge of customer applications and instrumentation, and it is committed to integrated informatics and informatics partnerships. Our two companies will form a strong team with the opportunity to make significant contributions to an even larger audience of life science researchers.'

About Silicon Genetics
Silicon Genetics is a leading provider of software solutions for life science discovery. With combined expertise in molecular biology and information technology, Silicon Genetics offers scalability that meets the demands of both high-throughput sample volumes and increasing numbers of users. Thousands of scientists at hundreds of organizations, including 12 of the world's top 13 pharmaceutical companies, currently use Silicon Genetics solutions to advance their research. Additional information about Silicon Genetics and its products and services can be found at www.silicongenetics.com.

Agilent in Life Sciences
Agilent's Life Sciences and Chemical Analysis (LSCA) business is a world-leading provider of instruments, supplies, software and services to the life science and chemical analysis markets. In 2003, these markets accounted for approximately 40 percent and 60 percent respectively of LSCA's $1.2 billion in revenue. Agilent's LSCA business is a global organization with 3,700 employees, five international manufacturing sites, and worldwide sales and support services to more than 22,000 customer organizations in more than 70 countries worldwide. It is a leading provider of microarray, microfluidic, liquid chromatography, gas chromatography and mass spectrometry-based solutions to pharmaceutical, biotech, academic, government and chemical organizations.

About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company's 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $6.1 billion in fiscal year 2003. Information about Agilent is available on the Web at www.agilent.com.

Forward-Looking Statement
This news release contains forward-looking statements, including, without limitation, statements relating to completion of the transaction and to the effect of the transaction on Agilent's financial condition and future business strategies, that involve risks and uncertainties that could cause results of Agilent Technologies and/or Silicon Genetics to differ materially from their respective management's current expectations. These include the timing and successful completion of product development, integration issues, the risks that the acquisition cannot be completed successfully or that anticipated benefits are not realized and the ability to retain Silicon Genetics' employees and customers as well as the risks and uncertainties that are detailed in Agilent's Annual Report on Form 10-K for the year ended Oct. 31, 2003, and its Quarterly Report on Form 10-Q for the quarter ended April 30, 2004, as filed with the Securities and Exchange Commission.

  Protein Research Marketing Insights
BioInformatics, LLC   23 Sep 2008
BIO-RAD ADDS CHEMOMETRICS ENHANCEMENTS TO VERSION 7.8 OF ITS KNOWITALL INFORMATICS SYSTEM FOR ADVANCED SPECTRAL AND CHEMICAL ANALYSIS
Bio-Rad Laboratories   20 Apr 2007
SomaVacc: The efficacious biotherapeutic cure for AIDS/Cancer via host T-cell remodulation
CanBiotech   29 Mar 2007
BLSC-2™ Auto Bench-Top Blister Packaging - Launch 2007
ATG Pharma Inc.   27 Feb 2007
Bio-Rad Announces Fall Web Seminars for Technology Advances in Spectral Analysis and Metabolomics
Bio-Rad Laboratories   18 Oct 2006
BIO-RAD RELEASES VERSION 7.5 OF ITS KNOWITALL INFORMATICS SYSTEM FEATURING A NEW EDITION FOR METABOLOMICS RESEARCH
Bio-Rad Laboratories   10 Aug 2006
BIO-RAD ANNOUNCES WEB SEMINAR SERIES IN SPECTROSCOPY, CHROMATOGRAPHY, ADME/TOX AND METABOLOMICS
Bio-Rad Laboratories   11 May 2006
Bio-Rad to Integrate CSIRO Molecular Modeling Technology Into Its KnowItAll Informatics System for In Silico ADME | Tox
Bio-Rad Laboratories   7 Apr 2006
Bio-Rad and Infometrix to Release KnowItAll Metabolomics Software Solution to Aid in Drug Discovery
Bio-Rad Laboratories   7 Apr 2006
Bio-Rad and Infometrix to Offer Analytical Informatics and Chemometrics Platform
Bio-Rad Laboratories   7 Apr 2006
Bio-Rad Introduces Technology for Comparative Visualization of Spectral, Chromatographic, and Other Graphical Data
Bio-Rad Laboratories   7 Apr 2006
Tactile Feedback Laser System for Robotic Surgery
University Technologies International   15 Mar 2006
Haloalkane Spectroscopy Probe
University Technologies International   15 Mar 2006
Tongue Retention Device for the Prevention of Snoring
University Technologies International   15 Mar 2006
Insufflation Method & Device
University Technologies International   15 Mar 2006
“Q-Linker” for Solid Phase Synthesis of DNA and RNA
University Technologies International   15 Mar 2006
A New Bovine Foot Rot Vaccine
University Technologies International   15 Mar 2006
Engineered Monomeric Streptavidin
University Technologies International   15 Mar 2006
A Transformed Insect Cell Protein Expression System
University Technologies International   15 Mar 2006
Novel Method of Expressing Proteins in Insect Cells
University Technologies International   15 Mar 2006
Novel Formulations for Treatment of Acute Asthma
University Technologies International   15 Mar 2006
New White Paper: CRM for Medical Device Manufacturers
OnPath Business Solutions   3 Feb 2006
Bio-Rad Releases Nineteen Specialized Infrared Spectral Data Collections
Bio-Rad Laboratories   3 Feb 2006
ADVITECH ANNOUNCES AGREEMENT FOR ITS PSORIASIS PRODUCT DERMYLEX WITH PHOTOMEDEX FOR THE U.S MARKET
Advitech Inc.   12 Jan 2006
ADVITECH ANNOUNCES AGREEMENT WITH COTHERA TO MARKET ITS PSORIASIS PRODUCT IN FRANCE
Advitech Inc.   15 Dec 2005
NEW POTENTIAL TREATMENT FOR INFLAMMATORY BOWEL DISEASES: ADVITECH ANNOUNCES POSITIVE RESULTS FROM PRECLINICAL STUDY
Advitech Inc.   6 Oct 2005
Bio-Rad Announces Fall Web Seminar Series
Bio-Rad Laboratories   2 Oct 2005
ADVITECH PROVIDES UPDATE ON ITS RECENT DEVELOPMENTS AND UPCOMING MILESTONES
Advitech Inc.   14 Sep 2005
Cryptosporidium hominis genes and gene products for chemotherepeutic, immunotherapeutic, immunoprophylactic, and diagnostic applications
Virginia Commonwealth University   1 Sep 2005
Nuclear Oxysterol, Potent Regulator of Cholesterol Homeostasis for Therapy of Hypercholesterolemia, Hyperlipidemia, and Atherosclerosis
Virginia Commonwealth University   1 Sep 2005
Go Back

Participating on CanBiotech's Networks
Using the Site   Privacy & Security

Advertise with us   Directory Guide & Access Policy
News & Event Postings  CanBiotech Newsletters

© 2000-2014 CanBiotech ™ Inc.